24477-92-7 Usage
Uses
Used in Pharmaceutical Industry:
METHYL 4-(4-AMINOPHENOXY)BENZOATE is used as an intermediate in the synthesis of pharmaceuticals for its potential biological activities, including anti-inflammatory and analgesic properties. Its unique structure allows it to be a valuable building block in the development of new drugs.
Used in Agrochemical Industry:
In the agrochemical industry, METHYL 4-(4-AMINOPHENOXY)BENZOATE is used as a precursor in the synthesis of various agrochemicals. Its ability to be functionalized and incorporated into different chemical structures makes it a versatile component in the creation of effective agrochemical products.
Used in Dye Industry:
METHYL 4-(4-AMINOPHENOXY)BENZOATE is also utilized in the dye industry for its potential to create a range of dyes with different color properties. Its chemical structure allows for the development of dyes with specific characteristics, making it a valuable component in dye formulation.
Used in Organic Synthesis:
As a building block in organic synthesis, METHYL 4-(4-AMINOPHENOXY)BENZOATE is used to create various functionalized benzoate derivatives. Its versatility in chemical reactions enables the synthesis of a wide array of compounds with diverse applications across different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 24477-92-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,4,4,7 and 7 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 24477-92:
(7*2)+(6*4)+(5*4)+(4*7)+(3*7)+(2*9)+(1*2)=127
127 % 10 = 7
So 24477-92-7 is a valid CAS Registry Number.
24477-92-7Relevant academic research and scientific papers
Discovery of orally available spirodiketopiperazine-based CCR5 antagonists
Nishizawa, Rena,Nishiyama, Toshihiko,Hisaichi, Katsuya,Hirai, Keisuke,Habashita, Hiromu,Takaoka, Yoshikazu,Tada, Hideaki,Sagawa, Kenji,Shibayama, Shiro,Maeda, Kenji,Mitsuya, Hiroaki,Nakai, Hisao,Fukushima, Daikichi,Toda, Masaaki
experimental part, p. 5208 - 5223 (2010/09/18)
Using the previously reported novel spirodiketopiperazine scaffold, the design and synthesis of orally available CCR5 antagonists was undertaken. Compounds possessing a carboxylic acid function in the appropriate position showed improved oral exposure (AU
Diarylether inhibitors of farnesyl-protein transferase
Dinsmore, Christopher J.,Williams, Theresa M.,Hamilton, Kelly,O'Neill, Timothy J.,Rands, Elaine,Koblan, Kenneth S.,Kohl, Nancy E.,Gibbs, Jackson B.,Graham, Samuel L.,Hartman, George D.,Oliff, Allen I.
, p. 1345 - 1348 (2007/10/03)
The design and synthesis of simple nonpeptide inhibitors of farnesyl-protein transferase (FTase) are described. Cysteine-derived diarylether frameworks are appropriate structural replacements for the C-terminal tetrapeptide portion of the Ras protein, and possess in vitro potency against FTase. Inhibitory activity is dependent on the ring-substitution pattern, and does not require the presence of a C-terminal carboxylate group.
